Altered expression of the glutamate transporter EAAT2b in neurological disease.
about
Current approaches to enhance glutamate transporter function and expressionThe complex molecular biology of amyotrophic lateral sclerosis (ALS)cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in ratsFinding new tricks for old drugs: an efficient route for public-sector drug discovery.Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1.SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease.Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis.Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression.Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic studyEffects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats.Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophreniaImpairment of neuronal glutamate uptake and modulation of the glutamate transporter GLT-1 induced by retinal ischemia.A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis.Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders.Differential regulation of glutamate transporter subtypes by pro-inflammatory cytokine TNF-α in cortical astrocytes from a rat model of amyotrophic lateral sclerosis.Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophreniaEffects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol.Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons?GLT-1-Dependent Disruption of CNS Glutamate Homeostasis and Neuronal Function by the Protozoan Parasite Toxoplasma gondii.Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement.The nuclear retention of transcription factor FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a neuroprotective role in the ageing brain.Biomarkers for amyotrophic lateral sclerosis.Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator.Effects of cefazolin and cefoperazone on glutamate transporter 1 isoforms and cystine/glutamate exchanger as well as alcohol drinking behavior in male alcohol-preferring rats.4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte culturesEffects of Amoxicillin and Augmentin on Cystine-Glutamate Exchanger and Glutamate Transporter 1 Isoforms as well as Ethanol Intake in Alcohol-Preferring RatsNeuroprotective Effects of the Glutamate Transporter Activator (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic Brain Injury in the Adult Rat.Functional modulation of the glutamate transporter variant GLT1b by the PDZ domain protein PICK1.Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients.Time-Dependent Compensatory Responses to Chronic Neuroinflammation in Hippocampus and Brainstem: The Potential Role of Glutamate NeurotransmissionProtein interacting with C kinase and neurological disorders.Amyotrophic lateral sclerosis: applications of stem cells - an update.Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.Tyrosine kinase inhibition reverses TDP-43 effects on synaptic protein expression, astrocytic function and amino acid dis-homeostasis.2,3,7,8-tetrachlorodibenzo-p-dioxin exposure influence the expression of glutamate transporter GLT-1 in C6 glioma cells via the Ca(2+) /protein kinase C pathway.Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease.Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons.Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia.How do Soluble Oligomers of Amyloid beta-protein Impair Hippocampal Synaptic Plasticity?
P2860
Q26996723-8F0C2B47-AC8A-4127-A29C-A0662F8F7A94Q28263899-29BFCCF0-A90D-46E4-BEFF-E338D4A60C16Q28602109-46C96999-F55B-468C-8044-AF6627A1FF7AQ33229063-4A93BDB4-FC7E-4732-BCA2-79C8CB55E2CDQ33313937-2B0A73D2-6B41-4C3C-8E72-C648A52D8786Q33531733-944623B3-75BF-4408-8B6A-F3EC6FBE69CAQ33742729-56F253BE-0ADB-4CF7-B644-F1F23F9C5C10Q33888584-2CD7DC5B-F947-442D-81F4-2354A998980CQ34184026-47531524-D081-4BBC-A736-2C7EEE0ABFB7Q34250509-B7A8C477-7FBE-4F5C-8841-B7E0CD749685Q34406087-32704FF4-7DA8-4ED8-8172-FFA410A2C070Q34924292-D9CDD5F9-D403-4C5B-9239-E0BC897926A9Q35015986-B59CCC89-89B0-434C-9474-D65E535A6513Q35022812-886A9ACB-B5E7-4F28-A0F6-18FEC88F4078Q35170318-0019CA4A-5208-4976-B7FF-D593DF817A55Q35657864-E1A7C25A-F819-4B79-B87A-88BF05ADD302Q35738010-A61B5D27-93DB-4298-A97D-7D3C52908205Q35791075-05CFC585-0FD0-4CDC-9EA2-86BA5539305BQ36047101-399CF3F2-C822-4DB4-8C1E-C0632D123E0EQ36052481-81BAD820-A813-4129-874E-6AD04EB35D68Q36360986-66A5CF0F-DAB0-4078-87DC-B7A0572B5B49Q36481118-4B4A6714-F668-4555-929B-515F1B327006Q36498596-AC6A1553-5E89-4472-8211-585D18741624Q36655883-F19AD88D-7A4B-4A2E-8A11-963414D62815Q36821506-27659099-9505-44E9-9C1F-AC665BE7DCB8Q36829679-344AA4AD-C665-4AAD-993C-E08B46BDF6B8Q36966650-18A40C75-58B1-467E-BAF0-8E5B3AA6AB9DQ37012384-192A3CD1-F544-40EE-A927-C8E55AACCCEEQ37132181-8EC00A10-8F0E-4CAE-9CA8-F6622E88EE12Q37612310-84DC816D-4A3F-4493-95AC-1A3F8401B82EQ38084249-73B36CAA-B7EB-49F5-A229-006394E4B1C6Q38160459-21BE9C98-5E35-4CE7-A6A5-2AF4A77194CDQ38223292-B6EACD6E-0664-426B-94EB-E992EE6A6493Q38512084-344129A3-7A5D-49E8-A158-14123DEBAA74Q38752798-F0421C4E-E3DA-420C-A3E5-C642DAAC3DF2Q38785323-0D6919A8-B092-4B83-BFB5-D52E7E68C23CQ38909797-1D078EE0-E6AF-4939-A9D8-325217770F8AQ39367072-7F26CCAD-EAD3-4321-9177-D50EE5490710Q39962383-B7B4147F-81F5-4C4F-9659-0FBD04A211C7Q40201381-D75A180D-5742-4CBB-9B29-50E1597BD00C
P2860
Altered expression of the glutamate transporter EAAT2b in neurological disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Altered expression of the glutamate transporter EAAT2b in neurological disease.
@en
type
label
Altered expression of the glutamate transporter EAAT2b in neurological disease.
@en
prefLabel
Altered expression of the glutamate transporter EAAT2b in neurological disease.
@en
P2093
P356
P1433
P1476
Altered expression of the glutamate transporter EAAT2b in neurological disease.
@en
P2093
Jeffrey D Rothstein
Margaret Dykes-Hoberg
Nicholas J Maragakis
P304
P356
10.1002/ANA.20003
P577
2004-04-01T00:00:00Z